Cardiovascular Information Systems Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Cardiovascular Ultrasound System Market is Segmented By Type (Stress Echocardiogram, Transesophageal Echocardiogram, Transthoracic Echocardiogram, Contrast Echocardiogram, Doppler Echocardiogram, Others), By Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound, Others), By Portability (Portable, Handheld), By End-User (Hospitals, Specialty Clinics, Cardiovascular Diagnostic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Report Overview

Global cardiovascular ultrasound system market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a high CAGR during the forecast period 2023-2030.

A cardiovascular ultrasound system also known as an echocardiography system is a medical imaging device used for non-invasive assessment and visualization of the heart and blood vessels within the body. It employs high-frequency sound waves (ultrasound) to create real-time images and videos of the heart's structure, function, and blood flow patterns. This technology is essential for diagnosing and monitoring various cardiovascular conditions, such as heart valve diseases, congenital heart defects, heart muscle disorders, vascular abnormalities and others.

Cardiac ultrasound should be performed with a low-frequency probe that has a small footprint that can fit between the ribs, using a cardiac setting. Ultrasound is defined as a frequency greater than 20,000 Hertz (Hz). The ultrasound probe sends sound waves, which the patient does not hear or feel, through the body. When the sound waves bounce off internal structures, the technology interprets the "echos" of the returning waves and reconstructs a moving picture of the patient’s heart in real-time.

Market Scope

For more insights - Request for Sample

Market Dynamics:

Drivers

Increasing demand for advanced cardiovascular ultrasound systems 

The increasing demand for advanced cardiovascular ultrasound systems is expected to drive the market over the forecast period. The advanced systems include artificial intelligence features that are responsible for better patient outcomes by performing minimally invasive procedures. These advanced systems helps to enable clinicians to acquire faster and more repeatable tests.

For instance, on August 25, 2023, Siemens Healthineers launched the Acuson Origin, a dedicated cardiovascular ultrasound system with new, robust artificial intelligence (AI) features. Designed to improve patient outcomes and help physicians perform minimally invasive cardiac procedures more efficiently, the Acuson Origin addresses the entire continuum of cardiovascular patient care, including diagnostic, structural heart, electrophysiological, and pediatric procedures.

Additionally, on October 12, 2020, GE Healthcare released U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

Moreover, ongoing advancements in ultrasound technology have led to the development of more advanced and sophisticated cardiovascular ultrasound systems. These systems offer higher image quality, improved diagnostic accuracy, and enhanced features such as 3D and 4D imaging, strain imaging, and contrast-enhanced imaging. These innovations make it easier to diagnose and treat cardiovascular conditions effectively. 

For instance, on January 22, 2023, Philips launched globally their next-generation compact cardiovascular portable ultrasound solution, the Compact 5000 Series. This new ultrasound is designed for portability and versatility without compromising image quality or performance and aims to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients.

In addition, the advanced devices helps to provide enhanced image quality and convenience. For instance, on September 30, 2021, Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, introduced the V8, a new premium cardiology ultrasound system that provides enhanced image quality, usability, and convenience for all medical professionals.

Further, the increasing prevalence of cardiovascular conditions, rising FDA approvals, rising demand for non-invasive diagnostic methods, increasing awareness and technological advancements in the development of novel systems are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications associated with the machines,  the high cost of the cardiovascular ultrasound systems and lack of trained professionals are expected to hamper the market. 

Segmentation Analysis

The global cardiovascular ultrasound system market is segmented based on type, technology, portability, end-user and region.

The transesophageal echocardiogram segment accounted for approximately 46.2% of the cardiovascular ultrasound system market share

The transesophageal echocardiogram segment is expected to hold the largest market share over the forecast period. A transesophageal echocardiogram is valuable for diagnosing conditions that may not be adequately visualized with other tests, and it is often used in cases of suspected infective endocarditis, aortic dissection, or complex valve pathology. The transesophageal echocardiography system is mainly used to manage and guide care for many cardiovascular patients.

For instance, on June 30, 2022, Clarius Mobile Health and ImaCor Inc. announced a partnership and launched a handheld transesophageal echocardiography (TEE) system designed to manage and guide care for the most critically ill patients in the Intensive Care Unit (ICU).

Moreover, a transesophageal echocardiogram shows a detailed view of the heart’s structure and function. It can help diagnose and manage many different cardiovascular conditions. The transesophageal echocardiogram uses transesophageal echocardiography for the diagnosis and management of many diseases.

In May 2022, Philips announced the international launch of EchoNavigator 4.0, EPIQ CVXi interventional cardiology ultrasound system. By integrating real-time transoesophageal echocardiography (TEE), which places the ultrasound transducer close to the heart, and X-ray fluoroscopy, EchoNavigator 4.0 helps interventional teams to decide, guide, treat, and confirm complex structural heart disease therapy, such as heart valve repair or replacement.

Geographical Share

North America accounted for approximately 39.2% of the market share 

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and technological advancements. North America especially the United States is very well known for its strong presence of major players such as pharmaceutical companies and medical device companies. The presence of major players actively performing in research activities, leads to the launch of advanced cardiovascular ultrasound systems with better features.

For instance, on August 25, 2023, GE HealthCare launched the Vscan Air SL, a handheld, wireless ultrasound imaging system designed for rapid cardiac and vascular assessments at the point of care to help clinicians accelerate diagnoses and treatment decisions. The latest addition to the Vscan product suite, Vscan Air SL features GE HealthCare’s proprietary SignalMax and XDclear technology that provide high levels of penetration, resolution, and sensitivity in imaging performance with an industry-leading single crystal transducer technology.

Furthermore, the technological advancements in the region is also a considerable factor in the region. North America is home to several universities and research institutions that collaborate with the healthcare industry. These collaborations lead to the development of technologically innovative cardiovascular ultrasound systems, which increases the knowledge about their benefits, leading to market dominance in the region.

Market Key Players

The major global players in the cardiovascular ultrasound system market include Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare, Hitachi, Ltd., CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, SAMSUNG HEALTHCARE, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., FUJIFILM Holdings Corporation, Whale Imaging Inc. and among others. 

Key Developments

• On June 23, 2023, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, released the announcement about the partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access to cardiac care. The new collaboration was announced at ASE 2023, the premier event for bringing together echo professionals.
• On January 27, 2023, FUJIFILM Sonosite, Inc., specialists in developing cutting-edge point-of-care ultrasound (POCUS) solutions, and part of the larger Fujifilm Healthcare portfolio, launched the new Sonosite PX ultrasound system. Sonosite PX is the next generation in Sonosite POCUS, with the most advanced image clarity ever seen in a Sonosite system, a suite of workflow efficiency features, and an adaptable form factor.
• In April 2022, FUJIFILM Sonosite, Inc. launched a new T8-3 transesophageal transducer and Cardiac Resuscitation exam type, to assist clinicians in using transesophageal ultrasound (TEU) at the point of care.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global cardiovascular ultrasound system market. During the early stages of the pandemic, many healthcare facilities postponed or canceled elective medical procedures, including non-urgent cardiac imaging tests such as cardiovascular ultrasounds. This led to a temporary decline in the demand for cardiovascular ultrasound systems. The pandemic also disrupted the supply chain of these devices globally.

Why Purchase the Report?

• To visualize the global cardiovascular ultrasound system market segmentation based on type, technology, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of cardiovascular ultrasound system market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global cardiovascular ultrasound system market report would provide approximately 69 tables, 71 figures, and 188 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies